Answer
Rifampicin decreased etrasimod exposure (AUC) by 49% when co-administered with etrasimod arginine; co-administration is not recommended.
Sources for this answer
- Velsipity 2 mg film-coated tabletsPfizer Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 5Document updated
Sources checked